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ABSTRACT 
We compared physiological responses corresponding to speeds at plasma lactate markers 
between incremental treadmill running of 4 and 8 min stages in fifteen healthy men (23 ± 4 
yrs, 1.78 ± 0.49 m, 72.7 ± 10.8 kg).Treadmill speed, oxygen uptake (V O2), heart rate (HR), 
rating of perceived exertion (RPE) and plasma lactate were measured for each stage, and 
calculated at: fixed blood lactate accumulation (FBLA) 4.0 mmol/L, an initial 1 mmol/L rise, 
deviation maximum (Dmax), lactate threshold (LT) and log-log LT. There was no effect 
(p>0.05) of stage duration on speed, V
 O2, HR and RPE at fixed markers. For 8 min stages, 
speed was lower at modelled markers: Dmax (-1.1 km/h; p=0.001), LT (-0.9 km/h; p=0.008) 
and log-log LT (-0.8 km/h; p=0.006), yet RPE was higher and V O2 lower for LT (1.1, p= 
0.02; -0.27 L/min, p=0.01) and log-log LT (1.4, p=0.03; -0.29 L/min, p=0.002). Lactate and 
V O2 were greater at 8 km/h for 4 min (p=0.0001), then similar until 11 km/h, with a trend 
towards elevated plasma lactate for 4 min thereafter. When applying lactate threshold 
markers to assess physiological responses to incremental running, protocols using prolonged 
stage durations may underestimate marker running speed. 
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INTRODUCTION 
Incremental exercise with measurement of physiological responses, coupled with blood 
lactate sampling, is used to predict endurance performance (Coyle, 1999; Roecker, Schotte, 
Niess, Horstmann & Dickhuth, 1998) prescribe exercise intensity and monitor adaptation 
(Bentley, Newell & Bishop, 2007). Aerobic capacity and the anaerobic threshold (AT) can be 
assessed in this manner during sub-maximal tests (Davis, 1985; Wasserman, Whipp, Koyl & 
Beaver, 1973) in both athletic (Coen, Urhausen & Kindermann, 2001) and clinical 
populations (Katz, Berkowitz & Lejemtel, 1992). Running speed eliciting AT has greater 
association with endurance performance in comparison to other predictive indices such as 
running economy, maximal oxygen uptake (V O2max) and muscle fibre composition (Farrell, 
Wilmore, Coyle, Billing & Costill, 1979; Sjodin & Jacobs, 1981). To better describe the 
workload -response relationship, fixed and modelled lactate markers can be calculated from 
blood samples collected at each increment. Lundberg et al (1986) established the LT via a 
computational method, whereby the lactate-workload response was modelled with two phase 
linear regression. Advancing upon this, Beaver and colleagues (1985) suggested applying a 
log transform to both lactate and workload values. Alternatively, fixed blood lactate 
accumulations (FBLA), such as 2.0 and 4.0 mmol/L (Heck et al., 1985; Kindermann, Simon 
& Keul, 1979) and the initial 1 mmol/L
 
rise from baseline, rely upon blood lactate 
concentration responding in a monotonous, curvilinear fashion to workload increments. Fixed 
markers allow ease of use, yet ignore individual lactate variability at rest and during exercise. 
Considering individual variation, the deviation maximum (Dmax) detects workload yielding 
the maximum perpendicular from a line connecting the first and the final lactate-workload 
points to the estimated polynomial (Cheng et al., 1992). The calculation of the workload 
corresponding to the Dmax is therefore dependent on the individual’s resting blood lactate 
concentration. 
Lactate kinetics are sensitive to exercise incrementation rate and duration, both of which may 
be manipulated according to sporting performance demands and the individual (Stockhausen, 
Grathwohl, Burklin, Spranz & Keul, 1997). Typically stage increments between 3 and 6 min 
duration are used, based upon the attainment of lactate and oxygen uptake (V O2) steady-
states (Bentley, Newell & Bishop, 2007). Previous research have found shorter stage 
durations to result in overestimation of the AT (Coen, Urhausen & Kindermann, 2001; 
Whipp, Davis, Torres & Wasserman, 1981), in addition to increasing workload at the LT 
(Bentley, McNaughton & Batterham, 2001). The latter reported 3 min stage increments had 
the effect of elevating power output at LT, in comparison to 8 min stages for cycling exercise. 
Yet, no effect was seen for workload, V O2 and heart rate (HR) at the FBLA 4.0 mmol/L. Step 
durations less than 3 min are unlikely to satisfy steady-state, and thus physiological response 
corresponding to particular lactate markers. Prolonged stages, in contrast, may allow lactate 
equilibrium, yet compromise peak V O2 attainment and promote premature fatigue. Differing 
muscular recruitment patterns (Beneke & von Duvillard, 1996) and maximal lactate steady-
state responses (Beneke, Leithauser & Hutler, 2001)
 
make direct comparisons between 
running and cycling difficult. For running, stages beyond 6 min have been recommended 
with the FBLA 4.0 mmol/L to avoid delay in blood lactate response (Foxdal, Sjodin & 
Sjodin, 1996). To expand upon findings of Bentley’s (2001) and Foxdal’s (1996) groups, our 
aim was to examine physiological responses corresponding to speeds at lactate markers using 
incremental treadmill running of traditional, 4 min, and prolonged, 8 min stage durations. 
 
MATERIALS AND METHODS 
Participants 
Fifteen healthy men (mean ± SD; age 23 ± 4 yrs, height 1.78 ± 0.49 m, body mass 72.7 ± 
10.8 kg) volunteered and provided written informed consent for participation in the study. 
Volunteers completed a medical and an International Physical Activity Questionnaire 
(IPAQ), conforming to high levels of habitual physical activity (2877.5 ± 1304.4 
MET·min/wk) (Bauman et al., 2009). Ethical approval for the research protocol was 
approved of by the University of Chichester Ethics Committee and conducted in accordance 
with the Helsinki Declaration. 
 
Procedures 
Participants visited the same temperature controlled laboratory (19 – 22°C) on five occasions 
to perform: a familiarisation, and repeated incremental running trials of 4 and 8 min stages in 
a randomised order within a four wk period (Schematic 1). All were instructed to refrain from 
strenuous exercise 24 h prior to each visit and a minimum of 48 h was allocated between 
sessions. Volunteers reported to the laboratory euhydrated, having not eaten, or consumed 
caffeine 3 h prior. Participants ran at a 1% gradient with an incrementation rate of 1 km/h 
every 4 or 8 min on a Woodway Ergo ELG 70 powered treadmill (Weil am Rhein, Germany). 
Subsequently, lactate-speed data was plotted using lactate analysis software (Newell et al., 
2007) with treadmill speed, V O2, HR and rating of perceived exertion (RPE) calculated 
corresponding to the markers: FBLA 4.0 mmol/L, an initial 1 mmol/L rise, Dmax, LT and log-
log LT. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SCHEMATIC 1. Schematic diagram of methodology and incremental exercise protocol for 
4 and 8 min stage trials (trial order was randomised; above is an example of trial sequence). 
 
Trials began with explanation of experimental protocol, then height was measured with a 
free-standing stadiometer (Holtain Ltd., Crymych, UK) and body mass using digital health 
scales (Seca Ltd., Birmingham, UK). All were familiarised with Borg’s scale (Borg, Hassmen 
& Lagerstrom, 1987) for RPE and positioned with a heart rate monitor (Polar Electro Oy, 
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Kempele, Finland). At rest, heart rate and plasma lactate were recorded in the final 30 s of a 5 
min, seated period. Next participants warmed up at 8 km/h for 5 min on the treadmill. 
Following a brief interval, exercise commenced with participants lowering themselves onto 
the treadmill belt when the start speed of 8 km/h was attained. Volunteers performed between 
four and ten stages with an incrementation rate of 1 km/h every 4 or 8 min. Participants were 
asked for RPE in the final 30 s of each stage, before straddling the treadmill upon stage 
completion during which a finger-tip capillary blood sample was collected. 
 
Measurement Procedures 
Respiratory gases were monitored breath-by-breath, concurrent with HR, using a portable 
metabolic cart (Cosmed K4b
2
, Rome, Italy). Prior to each trial, the system was calibrated 
according to manufacturer’s recommendations (Cosmed K4b2 User Manual). For analysis, 
V O2 and HR were recorded as 30 s averages, and then reported during the final 30 s of each 
stage with treadmill speed, RPE and blood lactate concentration. 
 
Plasma lactate was analysed via a ~25 µl finger prick blood sample collected from the right 
index finger from an incision made using a Haemolance plus high flow lancet (HaeMedic 
AB, Munka Ljungby, Sweden). At rest and on stage completion, fingertip capillary blood 
samples were drawn into non-lysed, EDTA-treated microvettes (Sarstedt Aktiengesellschaft 
& Co., Nümbrecht, Germany) and analysed in duplicate for plasma lactate (2300 STAT 
Plus™, YSI Life Sciences, Yellow Springs, USA). Where lactate concentrations varied less 
than 0.4 mmol/L between samples, the mean was reported. Where lactate concentration 
varied greater than 0.4 mmol/L, a third analysis was conducted with the mean of the two 
closest samples recorded (Grant et al., 2002). Lactate analysis software (Newell et al., 2007) 
was used to establish treadmill speed, V O2, HR and RPE at the lactate markers: FBLA 4.0 
mmol/L, the initial 1 mmol/L rise, Dmax, LT and log-log LT. 
 
Statistical Analysis 
Physiological responses between 4 and 8 min stages were analysed by a Student’s t-test for 
paired samples. One-way repeated measures analyses of variance (ANOVA) with pairwise 
comparisons were used to assess mean lactate and V O2 for: 4 min, 4 min at 8 min, and 8 min 
stages. Statistical analyses were calculated using PASW Statistics 18.0 for Windows 
(California, USA) with statistical significance set to a Type I error level of p<0.05. 
 
RESULTS 
Mean maximal running speed was faster during 4 min (14.4 ± 1.4 km/h; p=0.001), in 
comparison to 8 min trials (12.6 ± 1.3 km/h) (Table 1). There was no effect of duration on 
speed, V O2, HR and RPE at fixed markers: FBLA 4.0 mmol/L and the initial 1 mmol/L rise. 
Speed, V O2 and HR were similar; yet RPE appeared elevated for 4 min at the FBLA 4.0 
mmol/L (0.7; p=0.46) and the initial 1 mmol/L rise (0.9; p=0.38), in comparison to 8 min. For 
8 min, speed was lower at modelled markers: Dmax (-1.1 km/h; p=0.001), LT (-0.9 km/h; 
p=0.008) and log-log LT (-0.8 km/h; p=0.006), with HR unchanged between stage durations 
at respective markers. RPE was higher and V O2 lower at the LT (1.1, p=0.02; -0.27 L/min, 
p=0.01) and log-log LT (1.4, p=0.03; -0.29 L/min, p=0.002) for 8 min trials. This was not 
observed for Dmax (p=0.11). 
TABLE 1. Physiological responses corresponding to speed at fixed and modelled plasma lactate markers during incremental treadmill running 
trials of 4 and 8 min stage durations (mean ± SD). 
Plasma lactate marker 
4 min trial 8 min trial 
Speed (km/h) 
HR 
(beats/min) 
V O2 
(L/min) 
RPE Speed (km/h) 
HR 
(beats/min) 
V O2 
(L/min) 
RPE 
FBLA (4.0 mmol/L) 12.9 ± 1.5 183.6 ± 8.6 3.78 ± 0.53 15.3 ± 1.5 13.0 ± 1.9 186.6 ± 12.4 3.65 ± 0.45 14.6 ± 1.9 
Initial 1 mmol/L  rise 10.7 ± 1.8 169.0 ± 13.6 3.32 ± 0.65 16.2 ± 1.8 11.0 ± 1.5 167.5 ± 14.7 3.33 ± 0.52 15.3 ± 1.8 
Dmax 13.3 ± 1.4 184.2 ± 8.5 4.00 ± 0.82 16.2 ± 1.1 12.2 ± 1.8 * 182.1 ± 14.5 3.80 ± 0.72 16.3 ± 0.9 
LT 11.4 ± 1.2 175.8 ± 7.8 3.51 ± 0.48 14.7 ± 1.3 10.5 ± 0.9 * 170.3 ± 15.9 3.26 ± 0.48* 15.8 ± 1.6 * 
Log-log LT 10.4 ± 0.9 171.6 ± 11.0 3.39 ± 0.54 13.3 ± 1.9 9.6 ± 0.6 * 160.5 ± 15.0 3.08 ± 0.53* 14.7 ± 2.1 * 
* Significant difference from 4 min values, p<0.05. 
 
TABLE 2. Plasma lactate concentration at the completion of each running speed (km/h) during incremental treadmill running trials of 4 and 8 
min stage durations, as well as for 4 min at 8 min (mean ± SD). 
Speed (km/h) 
4 min trial 8 min trial  
Speed (km/h) 
4 min trial 8 min trial  
4 min lactate 
(mmol/L) 
4 min lactate 
(mmol/L) 
8 min lactate 
(mmol/L) 
4 min lactate 
(mmol/L) 
4 min lactate 
(mmol/L) 
8 min lactate 
(mmol/L) 
8   (n = 15) 1.3 ± 0.5 1.3 ± 0.6 1.1 ± 0.6 *† 13 (n = 8) 4.5 ± 2.2 3.3 ± 1.5 3.0 ± 1.4 
9   (n = 15) 1.5 ± 0.7 1.4 ± 0.7 1.4 ± 0.8 14 (n = 6) 4.7 ± 1.9 3.4 ± 1.4 3.3 ± 2.0 
10 (n = 15) 1.9 ± 0.9 1.8 ± 1.0 2.0 ± 1.2 15 (n = 2) 4.7 ± 1.8 2.9 ± 0.8 4.1 ± 1.5 
11 (n = 15) 2.5 ± 1.4 2.5 ± 1.5 2.8 ± 1.9 *† 16 (n = 2) 6.3 ± 1.9 4.5 ± 1.1  
12 (n = 12) 3.5 ± 2.1 3.2 ± 2.2 2.8 ± 1.7 17 (n = 2) 7.3 ± 1.1   
* Significant difference from 4 min values, p<0.05. † Significant difference from 4 min at 8 min values, p<0.01. n= participant number. 
Following stage one (8 km/h), plasma lactate concentration was 0.2 mmol/L lower for 8 min 
than 4 min (p=0.008), and 4 min at 8 min (p=0.03) respectively. Thereafter, plasma lactate 
was similar until the end of stage four (11 km/h) (p=0.05). For subsequent speeds (12 to 15 
km/h), there was a trend towards higher lactate concentrations during 4 min stages, than 8 
min (Table 2). For example, at 12 km/h  lactate was 3.5 mmol/L for 4 min and 2.8 mmol/L 
for 8 min. At 13 km/h lactate was 4.5 mmol/L for 4 min and 3.0 mmol/L for 8 min, 
respectively. 
 
Mean V O2 was elevated during 4 min (2.91 L/min), in comparison to 8 min trials (2.57 
L/min; p=0.0001), following the first stage, 8 km/h until 11 km/h (Figure 1). At 4 min during 
8 min, mean V O2 was also reduced when compared to that measured at the stage end, at 8 
min (2.48 L/min; p=0.0002). At 9 km/h during 4 min stages, V O2 (3.17 L/min) remained 
above both, 4 min at 8 min (2.86 L/min; p=0.0001) and 8 min (2.89 L/min; p=0.001). At 10 
and 11 km/h, V O2 was similar between stage lengths, and no difference was observed above 
11 km/h. This may be attributable to fewer participants completing stage increments above 
this speed, resulting in insufficient paired data sets for statistical analysis. In accordance to 
our plasma lactate data, for 12 km/h V O2 sampled was not different between 4 (3.61 L/min) 
and 8 min stages (3.4 L/min) (p=0.13). Dissimilar to our plasma lactate response, at 13, 14 
and 15 km/h, V O2 for 8 min appeared to rise steeply, V O2 showing a trend of surpassing that 
of 4 min trials at 14 and 15 km/h. Therefore, the effect of stage duration on V O2 response was 
not reflected by plasma lactate response at running speeds above 12 km/h. 
FIGURE 1. Oxygen uptake (V O2) (L/min) measured at the completion of each running speed 
(km/h) during incremental running trials of 4 and 8 min stages, as well as for 4 min at 8 min 
(mean ± SD). * Significant difference from 4 min values, p<0.05. 
 
DISCUSSION 
The incrementation rate and stage duration of incremental exercise protocols are adapted 
according to activity-specific demands and the characteristics of the population under 
assessment. The purpose of the present study was to compare physiological responses (V O2, 
HR and RPE) corresponding to speeds at plasma lactate markers during repeat, incremental 
treadmill running trials of 4 and 8 min stage durations in young men. These findings suggest 
that trials using stage durations of 8 min have the effect of reducing the running speed, but 
increasing the perception of exercise intensity at the LT and log-log LT. Furthermore, there 
was no effect of stage duration on selected physiological responses when using the fixed 
plasma lactate markers: FBLA 4.0 mmol/L and the initial 1 mmol/L rise, in our cohort. 
 
Production and elimination of intramuscular lactate determines circulating blood lactate 
concentration (MacRae, Dennis, Bosch & Noakes, 1992), and as such, blood lactate responds 
in a steady-state manner at low- and moderate-running speeds sub LT. At speeds above the 
LT, blood lactate accumulation will occur, unabating even when the intensity is reduced to 
constant speed. Blood lactate response will only decrease when running speed is reduced to 
those intensities below the LT. The duration an individual is exposed to a workload during 
incremental exercise remains controversial. Previously, Yoshida and co-workers (1984) 
observed no difference in V O2 at the initial rise above baseline and FBLA 4.0 mmol/L during 
incremental cycling protocols of 1 and 4 min stages. However, workloads at the respective 
markers were greater for the shorter, 1 min stages. It has been proposed that stage increments 
of at least 3 min are adequate to reach lactate steady-state; stages of longer duration allow 
lactate diffusion to reach an equilibrium-state between muscle and blood, thus permitting 
greater sensitivity for blood lactate sampling (Billat, Sirvent, Py, Koralsztein & Mercier, 
2003). The reliability of 3 min increments to identify fixed blood lactate markers and the LT 
was tested by Weltman and colleagues (1990) in a cohort of male runners. Assessed against a 
discontinuous, criterion protocol of 10 min stages; the 3 min protocol elicited similar running 
speeds at the FBLAs: 2.0, 2.5 and 4.0 mmol/L and the LT, as well as V O2, suggesting high 
reliability. For repeat trials of 3 min increments, mean running speed and V O2 were 16.2 
km/h and 4.13 L/min at FBLA 4.0 mmol/L; and 13.0 km/h and 3.28 L/min at the LT, 
respectively. Dissimilarities in our data (12.9 km/h and 3.78 L/min at FBLA 4.0 mmol/L; 
11.4 km/h and 3.51 L/min at the LT) may be due to differences in the training status of 
populations sampled. Weltman et al (1990) 
 
recruited male runners accumulating a minimum 
of 40 km per wk; whereas we used recreationally active, male students who did not all 
undertake regular running. Following endurance training, higher running speeds can be 
attained at a specific lactate marker leading to a rightward shift in the lactate-speed 
relationship. If this does not sufficiently explain the disparities in our findings, marker 
suitability for stage duration may. Similarly to Weltman (1990) stage duration had no effect 
on running speed at FBLA 4.0 mmol/L; yet for 4 min stages we observed faster speed 
concomitant with elevated V O2 at LT. Being regular runners, it is plausible that their cohort 
had a superior lactate buffering capacity, allowing them to tolerate the 10 min criterion 
protocol to a greater extent than ours during the 8 min protocol. Thus, reaching metabolic 
breakpoint at similar running speeds to shorter stage durations, which may explain the 
attainment of LT at slower running speeds during 8 min stages in our investigation. 
Interestingly, workload at Dmax was elevated for 4 min, in comparison to 8 min trials, without 
influence upon V O2, HR and RPE. Previously we found poor reproducibility for the Dmax 
during repeat, 4 and 8 min protocols. Dmax identifies threshold speed corresponding to the 
maximal perpendicular of a line connecting the first and the final lactate concentrations from 
a third-degree polynomial lactate-speed curve; thus dependent upon the curve expressing a 
smooth, parabolic function (Figure 2). As can be seen in Figure 3, this marker is unsuitable 
with the occurrence of a breakpoint, and relies upon the individual exerting maximal effort 
throughout the trial. As little consensus exists to an established fitting procedure, it appears 
apt to consider the incremental protocol design when selecting lactate markers to determine 
exercise intensity and monitor adaptation. Furthermore, the practice of applying a single 
marker for analysis of lactate-workload relationships should be discouraged. 
 FIGURE 2. Plasma lactate-speed relationship for a single participant analysed from a 4 min 
stage incremental treadmill running trial with selected lactate markers (FBLA 4.0 mmol/L = 
11.1 km/h; initial 1 mmol/L rise = 9.2 km/h; Dmax = 9.9 km/h). 
 
FIGURE 3. Plasma lactate-speed relationship for a single participant analysed from a 4 min 
stage incremental treadmill running trial with selected lactate markers repeated less than a 
week after that of Figure 2  (FBLA 4.0 mmol/L = 11.4 km/h; initial 1 mmol/L rise = 9.5 
km/h; Dmax = 15.3 km/h). 
 
Previous studies have observed elevated lactate response during shorter stage protocols, when 
compared against longer stage increments (Bentley, McNaughton & Batterham, 2001; 
Kuipers, Rietjens, Verstappen, Schoenmakers & Hofman, 2003). To our knowledge, only one 
investigation has compared difference in blood lactate response to incremental running 
exercise of 4 and 8 min stages (Foxdal, Sjodin & Sjodin, 1996).
 
These authors found 4 and 6 
min stages insufficient to achieve lactate steady-state in a group of firemen and marathon 
runners. Furthermore, the greater relationship between blood lactate sampled from 
incremental and constant-speed exercise observed in the running cohort is indicative of a 
training-induced regulatory effect likely to influence the use of FBLA 4.0 mmol/L for 
training prescription. Here, faster running speed at the FBLA 4.0 mmol/L was noted for 4 
min, when compared to 8 min stages. In contrast, we found no effect of stage duration on 
speed at FBLA 4.0 mmol/L; we used non-lysed, plasma capillary samples, whereas Foxdal’s 
group (1996) used haemolysed capillary blood for analysis. Although capillary samples are 
known to reflect arterial lactate values, the disparity may be attributable to the non-
homogenous distribution of lactate in blood. Blood sampling and analysis media vary 
throughout the literature, making direct comparison of data difficult. Whole venous samples 
have been reported to produce lower concentrations than fingertip samples during 4 min stage 
incremental treadmill running (El-Sayed, George & Dyson, 1993). Analytically, samples 
from plasma tend to be higher than those of whole- and haemolysed blood (Williams, 
Armstrong & Kirby, 1992);
 
this is due to the erythrocyte membrane acting as a barrier to 
lactate transit between plasma and red blood cells with changing lactate concentration. 
Various have cited difference in workload at fixed lactate markers (Bishop, Smith, Kime, 
Mayo & Tin, 1992; Foxdal, Sjodin, Ostman & Sjodin, 1991; Williams, Armstrong & Kirby, 
1992), but not the LT (Robergs et al., 1990; Yoshida, 1984) when collecting from venous or 
capillary, and analysing via plasma or haemolysed blood. 
 A secondary, but important finding of this study was the possible dissociation of plasma 
lactate concentration and V O2 for faster running speeds during 4 min stage trials. There 
appeared an increased blood lactate response from stages five to seven (12 to15 km/h) during 
4 min stages, with the difference increasing with advancing stages (stage eight, mean plasma 
lactate concentrations: 6.3 mmol/L (4 min); 4.5 mmol/L (8 min)). This was reflected by an 
observation of higher V O2 from stages one to six (8 to13 km/h) during 4 min stages, yet by 
stages six and seven (14 and 15 km/h) V O2 during 8 min had exceeded that of 4 min. Mean 
maximal treadmill running speed achieved during 4 min trials was greater than that of 8 min 
trials, with the length of all 8 min trials in excess of 4 min trials. The contrasting natures of 
the two protocols impose specific physiological demands upon the individual, therefore 
influencing the particular selection of lactate markers and the subsequent prescription of 
training intensities. When comparing power output, HR and V O2 between 3 and 8 min stage 
protocols for incremental cycling, Bentley et al (2001) reported 3 min increments may be 
adequate when using the FBLA 4.0 mmol/L, but not the LT. Prolonged stages had the effect 
of increasing power output at the LT, which may explain the possible V O2 slow component 
observed for our 8 min trials. Lactate has been implicated as a causative factor leading to the 
V O2 slow component and muscle fatigue (Zoladz, Gladden, Hogan, Nieckarz & Grassi, 
2008). Steady-state V O2 occurs during low- to moderate-intensity exercise, however with 
transition to high-intensity exercise beyond the LT, V O2 rises continuously until the cessation 
of exercise (Whipp & Wasserman, 1972).
 
Once the LT has been surpassed during incremental 
running exercise, the V O2-speed relationship exhibits a non-proportional, curvilinear 
response indicative of muscular fatigue. In this manner, fixed plasma lactate markers may 
overestimate HR and V O2 when using stages of prolonged duration as such markers are 
unable to discern individual metabolic differences, and may lack sensitivity to distinguish 
influence of muscular fatigue. 
 
This investigation compared the treadmill speed, V O2, HR, and RPE at fixed and modelled 
plasma lactate markers from data recorded during repeat incremental running trials of 4 and 8 
min stages in healthy men. The findings suggest the 8 min trials have the effect of reducing 
the speed, but increasing the perception of exercise intensity at the LT and log-log LT. When 
assessing physiological responses for incremental treadmill running, the use of these markers 
with protocols of longer stage duration may underestimate marker running speed. Secondly, 
the observed dissociation of plasma lactate concentration and V O2 between 4 and 8 min trials 
suggests consideration of lactate marker usage in accordance to: participant training status 
and conditioning, exercise mode and step duration. 
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